Showing results (1841-1850 of 2,276) with videos related to
Sort By:
Pageof 228
Nature|August 22, 2006
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionCheryl L Day, Daniel E Kaufmann, Photini Kiepiela, et al.Physical Review Letters|October 3, 2001
Alignment delays in the N = Z nuclei (72)Kr, (76)Sr, and (80)ZrS M Fischer, C J Lister, D P Balamuth, et al.Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.Cell Research|November 12, 2025
Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapyYishuang Sun, Zijian Zhang, Haiou Li, et al.Cancer Immunology Research|October 18, 2017
Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal CancerYohei Masugi, Reiko Nishihara, Tsuyoshi Hamada, et al.Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.Science Immunology|January 16, 2021
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaquesKeith D Kauffman, Shunsuke Sakai, Nickiana E Lora, et al.JCI Insight|October 5, 2016
Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancerGrit S Herter-Sprie, Shohei Koyama, Houari Korideck, et al.Trauma Surgery & Acute Care Open|March 27, 2023
Screening and intervention for intimate partner violence at trauma centers and emergency departments: an evidence-based systematic review from the Eastern Association for the Surgery of TraumaAmanda L Teichman, Stephanie Bonne, Rishi Rattan, et al.Cell Chemical Biology|September 26, 2023
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapyHaisheng Yu, Jing Liu, Xia Bu, et al.Pageof 228